Skip to content
Search

Latest Stories

UK was too slow to act on COVID-19 initially: Keir Starmer

Britain was initially too slow to respond to the novel coronavirus outbreak and did not learn quickly enough from other countries, opposition Labour Party leader Keir Starmer said on Wednesday (15).

Prime minister Boris Johnson initially refrained from approving the stringent controls that other European leaders imposed but then closed down the country when projections showed a quarter of a million people could die in the UK.


So far, more than 12,000 people with COVID-19 have died in British hospitals, though new official data indicates the true death toll could be much larger.

"I think that some of the decisions made in the last few weeks were too slow and didn't learn quickly enough from other countries, let's not repeat that," Starmer told BBC Radio.

Starmer, a 57-year-old former prosecutor who won the leadership of the Labour Party earlier this month, is calling on the British government to publish its exit strategy from lockdown restrictions.

Governments around the world are grappling with how to reverse measures put in place to contain the outbreak and which are battering the global economy. Several European countries have announced plans or already begun to relax restrictions.

Starmer said mass testing was likely to play a big role in any exit strategy and the government needed to put the necessary planning, investment and infrastructure in place early.

Foreign minister Dominic Raab, who is deputising for Johnson while he recovers from COVID-19, said on Monday (13) he did not expect to make any changes to the restrictions for now. They are due to be reviewed on Thursday (16).

Starmer said Labour supported extending the measures in Britain but that to "maintain morale and hope", the public needed to have an idea of what is coming next.

"Overcoming this crisis requires taking the British public with you," Starmer said. "The government needs to be open and transparent... The silent pressures on communities across the country cannot be underestimated."

A British government source said all decisions would be guided by scientific advice and data.

"Talk of an exit strategy before we have reached the peak risks confusing the critical message that people need to stay at home in order to protect our NHS (National Health Service) and save lives," the source said.

The government promised on Wednesday to test all residents and employees of nursing homes who have COVID-19 symptoms after official data showed the death toll from the pandemic was far higher when the elderly in care were included.

(Reuters)

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less